Non-conformities during routine biomarker testing for lung and colon cancer

Posted 13/12/2018

Dear colleague,  

You are invited to participate in a study to evaluate the frequency of non-conformities during routine biomarker testing for lung and colon cancer.

The aim of this study is to benchmark different non-conformities between institutes in the UK, and to compare them with data that has already been collected from other European institutes. 

 All data will be handled anonymously and will be included in a Biomedical Science final year project and a further PhD thesis, as a joint initiative between the University of Leuven in Belgium under the supervision of Prof. Dequeker and the Queen Elizabeth Hospital Birmingham (QEHB), UK under the supervision of Mr. Brendan O'Sullivan.

It would be much appreciated if you could further forward this invitation to others who may be interested in doing so.  

 The completion of the questionnaire will take no more than 15 minutes of your time. 

To start the survey please CLICK HERE

We hope that we can gather representative data from all over the UK and would greatly appreciate it if you would take part in this study. 

Please do not hesitate to contact us with any questions you might have. 


Thank you in advance


Yann van Royen, Biomedical Science student at University of Leuven, Belgium  

Mr. Brendan O'Sullivan, Operations Manager in Molecular Pathology at QEHB

Dr. Philippe Taniere, Consultant Histopathologist at QEHB

Cleo Keppens, PhD student,Biomedical Quality Assurance Research Unit at KU Leuven Belgium

Prof Dequeker, Head of Biomedical Quality Assurance Research Unit at KU Leuven Belgium 

Go to top